Tranexamic acid for anemia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Jul 2024: Trial registered, NCT06519422
  2. 10 Aug 2026: Trial started, NCT06519422

The trials

NCT06519422: Tranexamic Acid for Anaemia Trial

State
Under way
Phase
Phase 3
People
4,000 planned
Started
10 Aug 2026
Primary completion
Aug 2028
Arms
Tranexamic acid (TXA)
Results
None posted
  1. 25 Jul 2024: Trial registered
  2. 10 Aug 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Cyclo-f, Cyklokapron, Espercil, Femstrual, Haematrix, Lysteda, Rikavarin, TRANEXAMIC ACID 1 G in 10 mL INTRAVENOUS INJECTION, SOLUTION, Transamin, Tranexamic Acid 500 MG, Tranexamic acid tablets.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.